Institutional Ownership
Vanda Pharmaceuticals Inc
CUSIP 921659108COMVNDAQ1 2026
13D / 13G Filings
41
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
18.2%
Max % of class reported
Institutional Holders
164
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
41 filings · latest Jan 21, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 21, 2026 | Blackrock Portfolio Management LLC | 13G/A | 5.5% | 3.25M | SEC |
| 2 | Jan 9, 2026 | Millennium Management LLC | 13G/A | 11.0% | 1.68M | SEC |
| 3 | Jul 1, 2025 | Millennium Management LLC | 13G | 11.0% | 3.12M | SEC |
| 4 | Apr 15, 2025 | Blackrock Portfolio Management LLC | 13G | 7.7% | 4.48M | SEC |
| 5 | Feb 7, 2025 | Blackrock, Inc. | 13G/A | 8.1% | 4.70M | SEC |
| 6 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 15.6% | 9.10M | SEC |
| 7 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 6.0% | 3.46M | SEC |
| 8 | Feb 13, 2024 | Renaissance Technologies LLC | 13G/A | 6.4% | 3.68M | SEC |
| 9 | Feb 9, 2024 | Dimensional Fund Advisors LP | 13G/A | 3.4% | 1.97M | SEC |
| 10 | Jan 23, 2024 | Blackrock Inc. | 13G/A | 14.5% | 8.35M | SEC |
31 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Vanda Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 7.28M | $50.28M |
| 2 | Renaissance Technologies LLC | 3.76M | $25.98M |
| 3 | State Street Corp | 3.02M | $20.84M |
| 4 | Aigh Capital Management LLC | 2.75M | $19.00M |
| 5 | Millennium Management LLC | 1.88M | $13.00M |
| 6 | Dimensional Fund Advisors LP | 1.77M | $12.24M |
| 7 | Aqr Capital Management LLC | 1.60M | $11.08M |
| 8 | Geode Capital Management, LLC | 1.44M | $9.97M |
| 9 | Two Sigma Investments, LP | 1.40M | $9.66M |
| 10 | Jacobs Levy Equity Management, Inc | 1.17M | $8.08M |